Proinflammatory Cytokine Release and Infusional Side-Effects after Anti-Thymocyte Globulin Serotherapy for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

被引:0
|
作者
Khanolkar, Rutvij A. [1 ]
Dookie, Stephanie [1 ]
Li, Na [2 ]
Khan, Faisal [3 ]
Storek, Jan [4 ]
机构
[1] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada
[2] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[3] Univ Calgary, Cumming Sch Med, Dept Pathol & Lab Med, Calgary, AB, Canada
[4] Univ Calgary, Dept Med, Calgary, AB, Canada
关键词
D O I
10.1182/blood-2023-189653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant
    Bryant, Adam
    Mallick, Ranjeeta
    Huebsch, Lothar B.
    Allan, David S.
    Atkins, Harold
    Anstee, Grizel
    Bence-Bruckler, Isabelle
    Hamelin, Linda
    Hodgins, Michael
    Sabloff, Mitchell
    Scrivens, Nicholas
    Maze, Dawn
    Bredeson, Christopher N.
    Kekre, Natasha
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S310 - S311
  • [22] Anti-thymocyte globulin (ATG) for steroid-resistant acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A costly therapy with limited benefits.
    Khoury, H
    Kashyap, A
    Brewster, C
    Gilfillan, KR
    Adkins, D
    Brown, R
    Miller, G
    Vij, R
    Westervelt, P
    Goodnough, LT
    Forman, S
    DiPersio, JF
    [J]. BLOOD, 1999, 94 (10) : 668A - 668A
  • [23] Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant
    Ruggeri, Annalisa
    Sun, Yuqian
    Labopin, Myriam
    Bacigalupo, Andrea
    Lorentino, Francesca
    Arcese, William
    Santarone, Stella
    Gulbas, Zafer
    Blaise, Didier
    Messina, Giuseppe
    Ghavamzadeh, Ardeshi
    Malard, Florent
    Bruno, Benedetto
    Diez-Martin, Jose Luis
    Koc, Yener
    Ciceri, Fabio
    Mohty, Mohamad
    Nagler, Arnon
    [J]. HAEMATOLOGICA, 2017, 102 (02) : 401 - 410
  • [24] Comparison of Different Rabbit Anti-Thymocyte Globulin Formulations in the Prophylaxis of Graft-Versus-Host Disease: A Systematic Review
    Dybko, Jaroslaw
    Giordano, Ugo
    Pilch, Justyna
    Mizera, Jakub
    Borkowski, Artur
    Mordak-Domagala, Monika
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (17)
  • [25] Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell/bone marrow transplantation - a protocol for a systematic Cochrane review
    Theurich, S.
    Fischmann, H.
    Shimabukuro-Vornhagen, A.
    Skoetz, N.
    Chemnitz, J. M.
    Holtick, U.
    Scheid, C.
    Beyersmann, J.
    von Bergwelt-Baildon, M.
    [J]. ONKOLOGIE, 2011, 34 : 285 - 285
  • [26] Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation
    Queralt Salas, Maria
    Atenafu, Eshetu G.
    Datt Law, Arjun
    Lam, Wilson
    Pasic, Ivan
    Chen, Carol
    Kim, Dennis
    Michelis, Fotios, V
    Gerbitz, Armin
    Howard Lipton, Jeffrey
    Mattsson, Jonas
    Kumar, Rajat
    Viswabandya, Auro
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 428.e1 - 428.e9
  • [27] Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Alanazi, Wael
    Chen, Shiyi
    Lipton, Jeffrey H.
    Kim, Dennis D.
    Viswabandya, Auro
    Kumar, Rajat
    Lam, Wilson
    Law, Arjun D.
    Al-Shaibani, Zeyad
    Mattsson, Jonas
    Michelis, Fotios V.
    [J]. ACTA HAEMATOLOGICA, 2021, 144 (01) : 66 - 73
  • [28] Cytokine trajectories and risk of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation
    Gjaerde, L. K.
    Zucco, A. G.
    von Stemann, J. H.
    Minculescu, L.
    Moller, J. A.
    Brooks, P. T.
    Hansen, M. B.
    Reekie, J.
    Ostrowski, S. R.
    Sengelov, H.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 200 - 201
  • [29] Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation
    Storb, Rainer
    Gyurkocza, Boglarka
    Storer, Barry E.
    Sorror, Mohamed L.
    Blume, Karl
    Niederwieser, Dietger
    Chauncey, Thomas R.
    Pulsipher, Michael A.
    Petersen, Finn B.
    Sahebi, Firoozeh
    Agura, Edward D.
    Hari, Parameswaran
    Bruno, Benedetto
    McSweeney, Peter A.
    Maris, Michael B.
    Maziarz, Richard T.
    Langston, Amelia A.
    Bethge, Wolfgang
    Vindelov, Lars
    Franke, Georg-Nikolaus
    Laport, Ginna G.
    Yeager, Andrew M.
    Huebel, Kai
    Deeg, H. Joachim
    Georges, George E.
    Flowers, Mary E. D.
    Martin, Paul J.
    Mielcarek, Marco
    Woolfrey, Ann E.
    Maloney, David G.
    Sandmaier, Brenda M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (12) : 1530 - 1538
  • [30] Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia
    Lv, Meng
    Zhang, Xiaohui
    Xu, Lanping
    Wang, Yu
    Yan, Chenhua
    Chen, Huan
    Chen, Yuhong
    Han, Wei
    Wang, Fengrong
    Wang, Jingzhi
    Liu, Kaiyan
    Huang, Xiaojun
    Mo, Xiaodong
    [J]. FRONTIERS OF MEDICINE, 2019, 13 (06) : 667 - 679